New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension

Clinical Science

Volumn 126, Issue 2, 2014, Pages 111-121

  Hernanz, Raquel ^a   Briones, Ana M ^b   Salaices, Mercedes ^b   Alonso, María J ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

Cyclo oxygenase; Hypertension; Mitochondria; Nadph oxidase; Prostanoid; Reactive oxygen species

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANTIOXIDANT; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIN 1; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; OXYGEN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTANOID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

APOPTOSIS; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CARDIOVASCULAR FUNCTION; CELL ADHESION; CELL AGING; CELL DIFFERENTIATION; CELL GROWTH; CELLULAR DISTRIBUTION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; HEART INJURY; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULITIS; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CARDIOVASCULAR SYSTEM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; HYPERTENSION; MITOCHONDRIA; NADPH OXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; REACTIVE OXYGEN SPECIES;

EID: 84885059930     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120651     Document Type: Review

References (160)

1. Rizzoni, D., Porteri, E., Boari, G. E., De Ciuceis, C., Sleiman, I., Muiesan, M. L., Castellano, M., Miclini, M. and Agabiti-Rosei, E. (2003) Prognostic significance of small-artery structure in hypertension. Circulation 108, 2230-2235
2. Heagerty, A. M., Heerkens, E. H. and Izzard, A. S. (2010) Small artery structure and function in hypertension. J. Cell. Mol. Med. 14, 1037-1043
3. Mulvany, M. J. (2012) Small artery remodelling in hypertension. Basic Clin. Pharmacol. Toxicol. 110, 49-55
4. Rizzoni, D. and Agabiti-Rosei, E. (2012) Structural abnormalities of small resistance arteries in essential hypertension. Intern. Emerg. Med. 7, 205-212
5. Briones, A. M., Arribas, S. M. and Salaices, M. (2010) Role of extracellular matrix in vascular remodeling of hypertension. Curr. Opin. Nephrol. Hypertens. 19, 187-194
6. Martinez-Lemus, L. A. and Galiñanes, E. L. (2011) Matrix metalloproteinases and small artery remodeling. Drug Discovery Today: Dis. Models 8, 21-28
7. Mathiassen, O. N., Buus, N. H., Sihm, I., Thybo, N. K., Mørn, B., Schroeder, A. P., Thygesen, K., Aalkjaer, C., Lederballe, O., Mulvany, M. J. and Christensen, K. L. (2007) Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J. Hypertens. 25, 1021-1026
8. Münzel, T., Sinning, C., Post, F., Warnholtz, A. and Schulz, E. (2008) Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann. Med. 40, 180-196
9. Pauletto, P. and Rattazzi, M. (2006) Inflammation and hypertension: the search for a link. Nephrol., Dial., Transplant. 21, 850-853
10. Savoia, C. and Schiffrin, E. L. (2006) Inflammation in hypertension. Curr. Opin. Nephrol. Hypertens. 15, 152-158
11. Briones, A. M., Alonso, M. J., Marín, J., Balfagón, G. and Salaices, M. (2000) Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries. Br. J. Pharmacol. 131, 185-194
12. Álvarez, Y., Briones, A. M., Balfagón, G., Alonso, M. J. and Salaices, M. (2005) Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J. Hypertens. 23, 767-777
13. Adeagbo, A. S., Zhang, X., Patel, D., Joshua, I. G., Wang, Y., Sun, X., Igbo, I. N. and Oriowo, M. A. (2005) Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension. J. Hypertens. 23, 1025-1036
14. Jia, Z., Guo, X., Zhang, H., Wang, M. H., Dong, Z. and Yang, T. (2008) Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress. Hypertension 52, 952-959
15. Jia, Z., Aoyagi, T. and Yang, T. (2010) mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 55, 539-546
16. Drummond, G. R., Selemidis, S., Griendling, K. K. and Sobey, C. G. (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discovery 10, 453-471
17. Ohnaka, K., Numaguchi, K., Yamakawa, T. and Inagami, T. (2000) Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35, 68-75
18. Touyz, R. M. (2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 90, 449-455
19. Wang, M., Lee, E., Song, W., Ricciotti, E., Rader, D. J., Lawson, J. A., Puré, E. and FitzGerald, G. A. (2008) Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117, 1302-1309
20. Beltrán, A. E., Briones, A. M., García-Redondo, A. B., Rodríguez, C., Miguel, M., Álvarez, Y., Alonso, M. J., Martínez-González, J. and Salaices, M. (2009) p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats. J. Hypertens. 27, 142-154
21. Virdis, A., Duranti, E. and Taddei, S. (2011) Oxidative stress and vascular damage in hypertension: role of angiotensin II. Int. J. Hypertens. 2011, 916310
22. Galán, M., Miguel, M., Beltrán, A. E., Rodríguez, C., García-Redondo, A. B., Rodríguez-Calvo, R., Alonso, M. J., Martínez-González, J. and Salaices, M. (2011) Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli. J. Hypertens. 29, 529-536
23. Cai, H., Griendling, K. K. and Harrison, D. G. (2003) The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471-478
24. Brown, D. I. and Griendling, K. K. (2009) Nox proteins in signal transduction. Free Radical Biol. Med. 47, 1239-1253
25. Pendyala, S. and Natarajan, V. (2010) Redox regulation of Nox proteins. Respir. Physiol. Neurobiol. 174, 265-271
26. Touyz, R. M. and Briones, AM. (2011) Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens. Res. 34, 5-14
27. Al Ghouleh, I., Frazziano, G., Rodriguez, A. I., Csányi, G., Maniar, S., St Croix, C. M., Kelley, E. E., Egaña, L. A., Song, G. J., Bisello, A. et al. (2013) Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc. Res. 97, 134-142
28. Ebrahimian, T. and Touyz, R. M. (2008) Thioredoxin in vascular biology: role in hypertension. Antioxid. Redox Signaling 10, 1127-1136
29. Pagano, P. J., Chanock, S. J., Siwik, D. A., Colucci, W. S. and Clark, J. K. (1998) Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 32, 331-337
30. Griendling, K. K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501
31. Li, J. M. and Shah, A. M. (2002) Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277, 19952-19960
32. Shen, W. L., Gao, P. J., Che, Z. Q., Ji, K. D., Yin, M., Yan, C., Berk, B. C. and Zhu, D. L. (2006) NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem. Biophys. Res. Commun. 339, 337-343
33. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K. and Leto, T. L. (2003) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17, 1502-1504
34. Dikalov, S. I., Dikalova, A. E., Bikineyeva, A. T., Schmidt, H. H., Harrison, D. G. and Griendling, K. K. (2008) Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radical Biol. Med. 45, 1340-1351
35. Chen, F., Pandey, D., Chadli, A., Catravas, J. D., Chen, T. and Fulton, D. J. (2011) Hsp90 regulates NADPH Oxidase activity and is necessary for superoxide but not hydrogen peroxide production. Antioxid. Redox Signaling 14, 2107-2119
36. Ahmarani, L., Avedanian, L., Al-Khoury, J., Perreault, C., Jacques, D. and Bkaily, G. (2013) Whole-cell and nuclear NADPH oxidases levels and distribution in human endocardial endothelial, vascular smooth muscle, and vascular endothelial cells. Can. J. Physiol. Pharmacol. 91, 71-79
37. Lambeth, J. D., Kawahara, T. and Diebold, B. (2007) Regulation of Nox and Duox enzymatic activity and expression. Free Radical Biol. Med. 43, 319-331
38. Touyz, R. M., Yao, G., Viel, E., Amiri, F. and Schiffrin, E. L. (2004) Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hypertens. 22, 1141-1149
39. Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M. and Schiffrin, E. L. (2004) Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22, 535-542
40. De Ciuceis, C., Amiri, F., Brassard, P., Endemann, D. H., Touyz, R. M. and Schiffrin, E. L. (2005) Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler., Thromb., Vasc. Biol. 25, 2106-2113
41. Briones, A. M., Rodríguez-Criado, N., Hernanz, R., García-Redondo, A. B., Rodrigues-Díez, R. R., Alonso, M. J., Egido, J., Ruiz-Ortega, M. and Salaices, M. (2009) Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension 54, 142-149
42. Martínez-Revelles, S., Avendaño, M. S., García-Redondo, A. B., Alvarez, Y., Aguado, A., Pérez-Girón, J. V., García-Redondo, L., Esteban, V., Redondo, J. M., Alonso, M. J. et al. (2013) Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid. Redox Signaling 18, 51-65
43. Montezano, A. C. and Touyz, R. M. (2012) Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann. Med. 44, S2-S16
44. Lass'egue, B., San Martín, A. and Griendling, K. K. (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364-1390
45. Schramm, A., Matusik, P., Osmenda, G. and Guzik, T. J. (2012) Targeting NADPH oxidases in vascular pharmacology. Vasc. Pharmacol. 56, 216-231
46. Dikalov, S. (2011) Crosstalk between mitochondria and NADPH oxidases. Free Radical Biol. Med. 51, 1289-1301
47. Widlansky, M. E. and Gutterman, D. D. (2011) Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid. Redox Signaling 15, 1517-1530
48. Lacy, F., Gough, D. A. and Schmid-Schönbein, G. W. (1998) Role of xanthine oxidase in hydrogen peroxide production. Free Radical Biol. Med. 25, 720-727
49. Landmesser, U., Spiekermann, S., Preuss, C., Sorrentino, S., Fischer, D., Manes, C., Mueller, M. and Drexler, H. (2007) Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler., Thromb., Vasc. Biol. 27, 943-948
50. Gao, Y. T., Roman, L. J., Martásek, P., Panda, S. P., Ishimura, Y. and Masters, B. S. (2007) Oxygen metabolism by endothelial nitric-oxide synthase. J. Biol. Chem. 282, 28557-28565
51. Schulz, E., Jansen, T., Wenzel, P., Daiber, A. and Münzel, T. (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox Signaling 10, 1115-1126
52. Santos, C. X., Nabeebaccus, A. A., Shah, A., Camargo, L. L., Filho, S. V. and Lopes, L. R. (2013) ER stress and Nox-mediated ROS signaling in the peripheral vasculature: potential role in hypertension. Antioxid. Redox Signaling, doi:10.1089/ars.2013.5262
53. Sato, M., Yokoyama, U., Fujita, T., Okumura, S. and Ishikawa, Y. (2011) The roles of cytochrome p450 in ischemic heart disease. Curr. Drug. Metab. 12, 526-532
54. Cho, K. J., Seo, J. M. and Kim, J. H. (2011) Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species. Mol. Cells 32, 1-5
55. Widder, J. D., Fraccarollo, D., Galuppo, P., Hansen, J. M., Jones, D. P., Ertl, G. and Bauersachs, J. (2009) Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 54, 338-344
56. Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G. and Dikalov, S. I. (2010) Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107, 106-116
57. McNally, J. S., Saxena, A., Cai, H., Dikalov, S. and Harrison, D. G. (2005) Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler., Thromb., Vasc. Biol. 25, 1623-1628
58. Schulz, E., Wenzel, P., Münzel, T. and Daiber, A. (2012) Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid. Redox Signaling, doi:10.1089/ars.2012.4609
59. Mollnau, H., Wendt, M., Szöcs, K., Lass'egue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L. et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90, E58-E65
60. Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E. and Harrison, D. G. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209
61. Dikalova, A. E., Góngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S. and Griendling, K. K. (2010) Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 299, H673-H679
62. 2 • - production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J. Biol. Chem. 276, 29251-29256
63. Seshiah, P. N., Weber, D. S., Rocic, P., Valppu, L., Taniyama, Y. and Griendling, K. K. (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91, 406-413
64. García-Redondo, A. B., Briones, A. M., Beltrán, A. E., Alonso, M. J., Simonsen, U. and Salaices, M. (2009) Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+ , and superoxide anion levels. J. Pharmacol. Exp. Ther. 328, 19-27
65. Kuzkaya, N., Weissmann, N., Harrison, D. G. and Dikalov, S. (2005) Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem. Pharmacol. 70, 343-354
66. Doughan, A. K., Harrison, D. G. and Dikalov, S. I. (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102, 488-496
67. García-Cohen, E. C., Marin, J., Diez-Picazo, L. D., Baena, A. B., Salaices, M. and Rodriguez-Martinez, M. A. (2000) Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform. J. Pharmacol. Exp. Ther. 293, 75-81
68. Gao, Y. J. and Lee, R. M. (2001) Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A2 production. Br. J. Pharmacol. 134, 1639-1646
69. Zhou, M. S., Adam, A. G., Jaimes, E. A. and Raij, L. (2003) In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 42, 945-951
70. Alvarez, Y., Pérez-Girón, J. V., Hernanz, R., Briones, A. M., García-Redondo, A., Beltrán, A., Alonso, M. J. and Salaices, M. (2007) Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J. Pharmacol. Exp. Ther. 321, 381-388
71. Alvarez, Y., Briones, A. M., Hernanz, R., Pérez-Girón, J. V., Alonso, M. J. and Salaices, M. (2008) Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. Br. J. Pharmacol. 153, 926-935
72. Virdis, A., Colucci, R., Versari, D., Ghisu, N., Fornai, M., Antonioli, L., Duranti, E., Daghini, E., Giannarelli, C., Blandizzi, C. et al. (2009) Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 53, 1008-1016
73. Hernanz, R., Martín, A., Pérez-Girón, J. V., Palacios, R., Briones, A. M., Miguel, M., Salaices, M. and Alonso, M. J. (2012) Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function. Br. J. Pharmacol. 166, 1303-1319
74. Lacy, F., Kailasam, M. T., O'Connor, D. T., Schmid-Schönbein, G. W. and Parmer, R. J. (2000) Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36, 878-884
75. Paravicini, T. M. and Touyz, R. M. (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31, S170-S180
76. Rafikova, O., Rafikov, R., Kumar, S., Sharma, S., Aggarwal, S., Schneider, F., Jonigk, D., Black, S. M. and Tofovic, S. P. (2013) Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension. Free Radical Biol. Med. 56, 28-43
77. Cai, H. and Harrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844
78. Schulz, E., Gori, T. and Münzel, T (2011) Oxidative stress and endothelial dysfunction in hypertension. Hypertens. Res. 34, 665-673
79. Hu, L., Zhang, Y., Lim, PS., Miao, Y., Tan, C., McKenzie, K. U., Schyvens, C. G. and Whitworth, J. A. (2006) Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am. J. Hypertens. 19, 413-418
80. Wu, T. C., Chao, C. Y., Lin, S. J. and Chen, J. W. (2012) Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension. PLoS ONE 7, e46067
81. Graham, D., Huynh, N. N., Hamilton, C. A., Beattie, E., Smith, R. A., Cochemé, H. M., Murphy, M. P. and Dominiczak, A. F. (2009) Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54, 322-328
82. Suzuki, H., DeLano, F. A., Parks, D. A., Jamshidi, N., Granger, D. N., Ishii, H., Suematsu, M., Zweifach, B. W. and Schmid-Schönbein, G,W. (1998) Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. U.S.A. 95, 4754-4759
83. Viel, E. C., Benkirane, K., Javeshghani, D., Touyz, R. M. and Schiffrin, E. L. (2008) Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 295, H281-H288
84. Spiekermann, S., Schenk, K. and Hoeper, M. M. (2009) Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 34, 276
85. Laakso, J. T., Teräväinen, T. L., Martelin, E., Vaskonen, T. and Lapatto, R. (2004) Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats. J. Hypertens. 22, 1333-1340
86. Szasz, T., Linder, A. E., Davis, R. P., Burnett, R., Fink, G. D. and Watts, S. W. (2010) Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model. J. Cardiovasc. Pharmacol. 56, 627-634
87. Szasz, T., Davis, R. P., Garver, H. S., Burnett, R. J., Fink, G. D. and Watts, S. W. (2013) Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. PLoS ONE 8, e56046
88. George, J., Carr, E., Davies, J., Belch, J. J. and Struthers, A. (2006) High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114, 2508-2516
89. Feig, D. I., Soletsky, B. and Johnson, R. J. (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA, J. Am. Med. Assoc. 300, 924-932
90. Soletsky, B. and Feig, D. I. (2012) Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 60, 1148-1156
91. Higashi, Y., Sasaki, S., Nakagawa, K., Fukuda, Y., Matsuura, H., Oshima, T. and Chayama, K. (2002) Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am. J. Hypertens. 15, 326-332
92. Du, Y. H., Guan, Y. Y., Alp, N. J., Channon, K. M. and Chen, A. F. (2008) Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 117, 1045-1054
93. Porkert, M., Sher, S., Reddy, U., Cheema, F., Niessner, C., Kolm, P., Jones, D. P., Hooper, C., Taylor, W. R., Harrison, D. and Quyyumi, A. A. (2008) Tetrahydrobiopterin: a novel antihypertensive therapy. J. Hum. Hypertens. 22, 401-407
94. Vasquez-Vivar, J., Duquaine, D., Whitsett, J., Kalyanaraman, B. and Rajagopalan, S. (2002) Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterioscler., Thromb., Vasc. Biol. 22, 1655-1661
95. Kassan, M., Galan, M., Partyka, M., Saifudeen, Z., Henrion, D., Trebak, M. and Matrougui, K. (2012) Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. Arterioscler., Thromb., Vasc. Biol. 32, 1652-1661
96. Spitler, K. M., Matsumoto, T. and Webb, R. C. (2013) Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol., 305, H344-H353
97. Davidge, S. T. (2001) Prostaglandin H synthase and vascular function. Circ. Res. 89, 650-660
98. Tsatsanis, C. Androulidaki, A., Venihaki, M. and Margioris, A. N. (2006) Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654-1661
99. Montezano, A. C., Amiri, F., Tostes, R. C., Touyz, R. M. and Schiffrin, E. L. (2007) Inhibitory effects of PPAR-γ on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. J. Am. Soc. Hypertens. 1, 150-160
100. Peng, H., Chen, P., Cai, Y., Chen, Y., Wu, Q. H., Li, Y., Zhou, R. and Fang, X. (2008) Endothelin-1 increases expression of cyclooxygenase-2 and production of interleukin-8 in human pulmonary epithelial cells. Peptides 29, 419-424
101. Kane, M. O., Etienne-Selloum, N., Madeira, S. V., Sarr, M., Walter, A., Dal-Ros, S., Schott, C., Chataigneau, T. and Schini-Kerth, V. B. (2010) Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols. Pfluegers Arch. 459, 671-679
102. Martín, A., Pérez-Girón, J. V., Hernanz, R., Palacios, R., Briones, A. M., Fortuño, A., Zalba, G., Salaices, M. and Alonso, M. J. (2012) Peroxisome proliferator-activated receptor-? activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J. Hypertens. 30, 315-326
103. Félétou, M., Huang, Y. and Vanhoutte, P. M. (2011) Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br. J. Pharmacol. 164, 894-912
104. Samuelsson, B., Morgenstern, R. and Jakobsson, P. J. (2007) Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59, 207-224
105. Norel, X. (2007) Prostanoid receptors in the human vascular wall. Sci. World J. 7, 1359-1374
106. Mitchell, J. A., Ali, F., Bailey, L., Moreno, L. and Harrington, L. S. (2008) Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp. Physiol. 93, 141-147
107. Nakahata, N. (2008) Thromboxane A2: physiology/ pathophysiology, cellular signal transduction and pharmacology. Pharmacol. Ther. 118, 18-35
108. Félétou, M., Köhler, R. and Vanhoutte, P. M. (2010) Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr. Hypertens. Rep. 12, 267-275
109. Hernanz, R., Briones, A. M., Alonso, M. J., Vila, E. and Salaices, M. (2004) Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 287, H225-H234
110. Wong, S. L., Lau, C. W., Wong, W. T., Xu, A., Au, C. L., Ng, C. F., Ng, S. S., Gollasch, M., Yao, X. and Huang, Y. (2011) Pivotal role of protein kinase C delta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation. Arterioscler., Thromb., Vasc. Biol. 31, 1169-1176
111. Virdis, A., Colucci, R., Fornai, M., Duranti, E., Giannarelli, C., Bernardini, N., Segnani, C., Ippolito, C., Antonioli, L., Blandizzi, C. et al. (2007) Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 49, 679-686
112. Welch, W. J., Patel, K., Modlinger, P., Mendonca, M., Kawada, N., Dennehy, K., Aslam, S. and Wilcox, C. S. (2007) Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. Am. J. Physiol. Heart Circ. Physiol. 293, H2644-H2649
113. Wong, S. L., Wong, W. T., Tian, X. Y., Lau, C. W. and Huang, Y. (2010) Prostaglandins in action indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions. Adv. Pharmacol. 60, 61-83
114. Liu, B., Luo, W., Zhang, Y., Li, H., Zhu, N., Huang, D. and Zhou, Y. (2012) Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries. Am. J. Physiol. Renal Physiol. 302, F1133-F1140
115. Gluais, P., Paysant, J., Badier-Commander, C., Verbeuren, T., Vanhoutte, P. M. and Feletou, M. (2006) In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am. J. Physiol. Heart Circ. Physiol. 291, H2255-H2264
116. Blanco-Rivero, J., Cachofeiro, V., Lahera, V., Aras-Lopez, R., Márquez-Rodas, I., Salaices, M., Xavier, F. E., Ferrer, M. and Balfagón, G. (2005) Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 46, 107-112
117. Gomez, E., Schwendemann, C., Roger, S., Simonet, S., Paysant, J., Courchay, C., Verbeuren, T. J. and Félétou, M. (2008) Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats. Am. J. Physiol. Heart Circ. Physiol. 295, H2198-H2211
118. Xavier, F. E., Aras-López, R., Arroyo-Villa, I., Campo, L. D., Salaices, M., Rossoni, L. V., Ferrer, M. and Balfagón, G. (2008) Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin. Br. J. Pharmacol. 154, 1225-1235
119. Félétou, M., Verbeuren, T. J. and Vanhoutte, P. M. (2009) Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br. J. Pharmacol. 156, 563-574
120. Young, W., Mahboubi, K., Haider, A., Li, I. and Ferreri, N. R. (2000) Cyclooxygenase-2 is required for tumor necrosis factor-a- and angiotensin II-mediated proliferation of vascular smooth muscle cells. Circ. Res. 86, 906-914
121. Virdis, A., Colucci, R., Neves, M. F., Rugani, I., Aydinoglu, F., Fornai, M., Ippolito, C., Antonioli, L., Duranti, E., Solini, A. et al. (2012) Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur. Heart J. 33, 2225-2234
122. Qi, Z., Hao, C. M., Langenbach, R. I., Breyer, R. M., Redha, R., Morrow, J. D. and Breyer, M. D. (2002) Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J. Clin. Invest. 110, 61-69
123. Francois, H., Athirakul, K., Mao, L., Rockman, H. and Coffman, T. M. (2004) Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43, 364-369
124. Capone, C., Faraco, G., Anrather, J., Zhou, P. and Iadecola, C. (2010) Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension 55, 911-917
125. Wu, R., Duchemin, S., Laplante, M. A., De Champlain, J. and Girouard, H. (2011) Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension. Am. J. Hypertens. 24, 1239-1244
126. Cao, X., Peterson, J. R., Wang, G., Anrather, J., Young, C. N., Guruju, M. R., Burmeister, M. A., Iadecola, C. and Davisson, R. L. (2012) Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain. Hypertension 59, 869-876
127. Yu, Y., Ricciotti, E., Scalia, R., Tang, S. Y., Grant, G., Yu, Z., Landesberg, G., Crichton, I., Wu, W., Puré, E. et al. (2012) Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci. Transl. Med. 4, 132ra54
128. Wu, R., Laplante, M. A. and de Champlain, J. (2005) Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats. Hypertension 45, 1139-1144
129. Antman, E. M., DeMets, D. and Loscalzo, J. (2005) Cyclooxygenase inhibition and cardiovascular risk. Circulation 112, 759-770
130. Amer, M., Bead, V. R., Bathon, J., Blumenthal, R. S. and Edwards, D. N. (2010) Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale. Cardiol. Rev. 18, 204-212
131. Cheng, Y., Wang, M., Yu, Y., Lawson, J., Funk, C. D. and Fitzgerald, G. A. (2006) Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J. Clin. Invest. 116, 1391-1399
132. Wang, M., Ihida-Stansbury, K., Kothapalli, D., Tamby, M. C., Yu, Z., Chen, L., Grant, G., Cheng, Y., Lawson, J. A., Assoian, R. K. et al. (2011) Microsomal prostaglandin E2 synthase-1 modulates the response to vascular injury. Circulation 123, 631-639
133. Guan, Y., Zhang, Y., Wu, J., Qi, Z., Yang, G., Dou, D., Gao, Y., Chen, L., Zhang, X., Davis, L. S. et al. (2007) Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J. Clin. Invest. 117, 2496-2505
134. Chen, L., Miao, Y., Zhang, Y., Dou, D., Liu, L., Tian, X., Yang, G., Pu, D., Zhang, X., Kang, J. et al. (2012) Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility. Arterioscler., Thromb., Vasc. Biol. 32, 3024-3032
135. Sparks, M. A., Makhanova, N. A., Griffiths, R. C., Snouwaert, J. N., Koller, B. H. and Coffman, T. M. (2013) Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death. Hypertension 61, 166-173
136. Karaa, A., Kamoun, W. S., Xu, H., Zhang, J. and Clemens, M. G. (2006) Differential effects of oxidative stress on hepatic endothelial and Kupffer cell eicosanoid release in response to endothelin-1. Microcirculation 13, 457-466
137. Li, Y. B., Han, J. Y., Jiang, W. and Wang, J. (2011) Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells. Mol. Biol. Rep. 38, 2301-2306
138. Peng, T., Lu, X. and Feng, Q. (2005) NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J. 19, 293-295
139. Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M. and Araki, E. (2003) Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52, 2570-2577
140. Cho, H. K., Cheong, K. J., Kim, H. Y. and Cheong, J. (2011) Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4. Biochem. J. 435, 431-439
141. Rasheed, Z. and Haqqi, T. M. (2012) Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2a, p38-MAPK and NF-?B in advanced glycation end products stimulated human chondrocytes. Biochim. Biophys. Acta 1 823, 2179-2189
142. Tian, X. Y., Wong, W. T., Leung, F. P., Zhang, Y., Wang, Y. X., Lee, H. K., Ng, C. F., Chen, Z. Y., Yao, X., Au, C. L. et al. (2012) Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin F2a impairs endothelial function in renovascular hypertensive rats. Antioxid. Redox Signaling 16, 363-373
143. Wong, W. T., Tian, X. Y., Chen, Y., Leung, F. P., Liu, L., Lee, H. K., Ng, C. F., Xu, A., Yao, X., Vanhoutte, P. M. et al. (2010) Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ. Res. 107, 984-991
144. Feng, L., Xia, Y., Garcia, G. E., Hwang, D. and Wilson, C. B. (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-a, and lipopolysaccharide. J. Clin. Invest. 95, 1669-1675
145. Jaimes, E. A., Tian, R. X., Pearse, D. and Raij, L. (2005) Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int. 68, 2143-2153
146. Yang, D., Félétou, M., Boulanger, C. M., Wu, H. F., Levens, N., Zhang, J. N. and Vanhoutte, P. M. (2002) Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br. J. Pharmacol. 136, 104-110
147. Vanhoutte, P. M., Feletou, M. and Taddei, S. (2005) Endothelium-dependent contractions in hypertension. Br. J. Pharmacol. 144, 449-458
148. Barbieri, S. S., Amadio, P., Gianellini, S., Zacchi, E., Weksler, B. B. and Tremoli, E. (2011) Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase. FASEB J. 25, 3731-3740
149. Muzaffar, S., Shukla, N., Massey, Y., Angelini, G. D. and Jeremy, J. Y. (2011) NADPH oxidase 1 mediates upregulation of thromboxane A2 synthase in human vascular smooth muscle cells: inhibition with iloprost. Eur. J. Pharmacol. 658, 187-192
150. Zou, M., Martin, C. and Ullrich, V. (1997) Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol. Chem. 378, 707-713
151. Schildknecht, S. and Ullrich, V. (2009) Peroxynitrite as regulator of vascular prostanoid synthesis. Arch. Biochem. Biophys. 484, 183-189
152. Tang, E. H., Leung, F. P., Huang, Y., Feletou, M., So, K. F., Man, R. Y. and Vanhoutte, P. M. (2007) Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br. J. Pharmacol. 151, 15-23
153. Muzaffar, S., Shukla, N., Lobo, C., Angelini, G. D. and Jeremy, J. Y. (2004) Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2a, prostaglandin F2a, cytokines and endotoxin in the pig pulmonary artery. Br. J. Pharmacol. 141, 488-496
154. Muzaffar, S., Shukla, N., Bond, M., Sala-Newby, G. B., Newby, A. C., Angelini, G. D. and Jeremy, J. Y. (2008) Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate. Br. J. Pharmacol. 155, 847-856
155. Cogolludo, A. (2006) Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann. N.Y. Acad. Sci. 1091, 41-51
156. Bayat, H., Schröder, K., Pimentel, D. R., Brandes, R. P., Verbeuren, T. J., Cohen, R. A. and Jiang, B. (2012) Activation of thromboxane receptor modulates interleukin-1ß-induced monocyte adhesion-A novel role of Nox1. Free Radical Biol. Med. 52, 1760-1766
157. Pena-Silva, R. A. and Heistad, D. D. (2010) EP1c times for angiotensin: EP1 receptors facilitate angiotensin II-induced vascular dysfunction. Hypertension 55, 846-848
158. Malik, K. U., Jennings, B. L., Yaghini, F. A., Sahan-Firat, S., Song, C. Y., Estes, A. M. and Fang, X. R. (2012) Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents. Prostaglandins Other Lipid Mediators 98, 69-74
159. Sancho, P., Martín-Sanz, P. and Fabregat, I. (2011) Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway. Free Radical Biol. Med. 51, 1789-1798
160. Simonsen, U., Christensen, F. H. and Buus, N. H. (2009) The effect of tempol on endothelium-dependent vasodilatation and blood pressure. Pharmacol. Ther. 122, 109-124